OptimizeRx Blogs

The relationship between field reps and Healthcare Professionals (HCPs) plays a vital role in keeping medical practices abreast of treatment options and clinical...

In today’s complex healthcare landscape, keeping up with the latest therapies and treatments can be an overwhelming task for many healthcare professionals (HCPs) particularly...

Despite life sciences manufacturers’ considerable planning and investment in HCP engagement programs, too often their message falls short of reaching their target audience....

I recently had the chance to participate in a panel session at the Pharma CX Oncology Summit. Our topic was the oncologist customer experience – specifically how technology...

The phrases “omnichannel,” “artificial intelligence” and “next-best action” have become ubiquitous in conversations around how to overcome the challenges of reaching HCPs...

In life science brands’ quest for highly targeted, clinically-relevant HCP communications, EHR “trigger” data is an increasingly popular choice. Its benefits include accuracy...

Navigating the EHR Landscape: Market Challenges and Point-of-Care Solution

Life science brand’s need for effective HCP engagement solutions at the point of care (POC) is...

Omnichannel programs are at the forefront of today’s HCP engagement strategies – and for good reason. In a March 2023 survey, OptimizeRx found that physicians were actively...

Loss of exclusivity (LOE) is a milestone every novel pharmaceutical product reaches. In anticipation of generic competition and the resulting loss of market share/value,...

OptimizeRx is known for our ability to deliver life science brand messages and resources directly in the clinical workflow. As a result, we’re consistently asked by our...

Omnichannel marketing and artificial intelligence (AI) have made targeting clinical audiences easier and more precise. And yet, in the life sciences, we still tend to engage...

Terms like omnichannel, artificial intelligence (AI), data-driven, and real time are defining the conversation around HCP marketing – and for good reason. Today’s savviest...

Pharma and MedTech companies continue to spend billions marketing drugs and devices to physicians. In fact, according to Forbes, pharma spent nearly $4 billion on advertising...

OptimizeRx has released its second Environment, Social and Governance (ESG) report. The report details the Company’s efforts to align with, and show progress against, the 21...

Diabetes continues to plague the healthcare industry, maintaining its status as one of the top public health issues in terms of clinical outcomes and cost. The American...

How can life sciences brands leverage real-world data and AI-driven tools while safeguarding patient privacy?

The growing use of real-world data and AI-driven tools has...

This year, Pharma USA was all about omnichannel engagement, “next best action,” and grappling with how to view engagement data alongside more traditional health data to...

With life science manufacturers’ interest in EHR-based solutions for HCP engagement growing, navigating recent market growth and companies’ claims about EHR network access...

Continuing our tradition of supporting pressing causes that impact health, OptimizeRx joined with the American Foundation for Suicide Prevention (AFSP) to raise funds at the...

HCPs marketers continue to embrace digital channels as they pursue “omnichannel” strategies, but social media is often a misunderstood – or overlooked – channel to engage and...

How can we advance gender parity and celebrate the women forging innovation in healthcare?

How can medical device brands stay top-of-mind and provide the most value for physicians and patients?

As the healthcare landscape continues to evolve, successful digital...

Life science manufacturers’ interest in EHR-based solutions for HCP engagement continues to grow. But with companies’ varying claims about EHR network access and reach,...

Today’s life science manufacturers are crossing the threshold into the next era of digital and omnichannel innovations in healthcare provider (HCP) marketing. As channel...

Life science manufacturers’ interest in EHR-based solutions for HCP engagement is growing, but the recent and rapid growth in the market means that navigating various...

Using the EHR Workflow to Raise Awareness of New Medical Device Brand

According to the CDC, over 37 million people in the US suffer from diabetes, and recent research from...

The third annual Innovate4Outcomes® took place on December 1, 2022, with no shortage of creativity – and friendly competition – at the virtual design-thinking event.

HCP engagement in the digital marketing era

Sales representatives have long been a vital ingredient in life science companies' HCP engagement strategies – educating...

During my recent session at HLTH, I was given the opportunity to speak on the importance of a strong omnichannel strategy and how it can improve HCP engagement.

During my recent session at HLTH, I had the great opportunity to share a case study on how AI and real world data (RWD) increased medication affordability for patients by...

The Digital Point of Care: New Opportunities for Medical Device Marketing

It’s a scenario we’ve all been in: you have a doctor’s appointment about a new or worsening symptom....

Account-Based Marketing in Healthcare

Account-based marketing (ABM) continues to be an attractive solution for Life Science brands looking to gain traction and share-of-voice...

For the third annual Innovate4Outcomes®design-thinking event, our team chose to take on the global health concern of Antimicrobial Resistance, or AMR.

As medtech and medical device companies continue to advance their digital strategies, understanding and aligning with the digital patient journey have become more important...

Real-World Data (RWD) has become an essential element of pharmaceutical marketing, but as an industry we are far from utilizing its full potential. During my recent session...

Innovate4Outcomes® is a design-thinking, half-day event that brings together those interested in cross-industry collaboration to brainstorm potential pathways to reduce the...

Unlocking the Full Potential of Real-World Data

Real-World Data (RWD) has become an integral, inseparable element of omnichannel marketing (OCM), which is an increasingly...

Overcoming Disadvantaged Access Positions with Digital Tools at the Point-of-Care

In almost every therapy area, utilization management, prior authorizations, and step therapy...

There are more than 100 different types of arthritis, but osteoarthritis (OA) is the most common—impacting 32.5 Million US adults and creating an overall economic burden of...

Pre-existing condition. This is a term we heard thrown around a lot at the start of 2020. It’s still a part of our day-to-day vocabulary, especially if you're one of the...

When pharma brands become fully digitally enabled, market access pathways are optimized and providers have the tools they need to begin patients on your therapy rapidly and...

The 2022 State of Mental Health in America report highlights that 24.7% of adults with a mental illness in 2019 reported an unmet need for treatment—this number has seen a...

During the recent Digital Pharma Innovation Week, I had the great opportunity to lead a roundtable discussion with a group of stakeholders from across the pharma industry...

As pharmaceutical companies evolve toward digital-first commercial models, U.S. market access strategies seem to be lagging in the digital revolution. Companies face many...

Non-adherence to prescribed therapy can create extraordinary risks for patients. Even when provided with correct diagnoses and effective treatment plans, patients can often...

At the recent Asembia Specialty Pharmacy Summit, I had the chance to join RxNT, a leading EHR provider, to host a small-format session on the EHR workflow. In light of recent...

There may be no greater threat to patient outcomes than the current barriers to therapy access—especially for specialty medications.

Growth in healthcare technology began with the HITECH (Health Information Technology for Economic and Clinical Health) Act of 2009 and has grown significantly over the years....

Every day, patients switch to new therapies because of disease progression, side effects, affordability or other factors—potentially delaying patient recoveries, negatively...

Over the past decade, pharma has made significant investments in real-world data (RWD) and in analytics/insights generated from that data. At OptimizeRx, we’re applying this...

It’s a problem with an enormous impact on patients that has been nearly impossible to solve: Brand-eligible patients are out there, but they’ve been misdiagnosed or, even...

Offering a Practical Approach to AI and Real World Data

Despite incredible advances in the availability of real-world data (RWD) and AI applications, many tech-savvy brand...

Exploring the Current State of Patient Journey Planning

In the quest to improve patient outcomes, life sciences companies are increasing their focus on optimizing the patient...

AI in Pharma Marketing is a Hot Topic – But Execution Lags Behind Ideation

If you’re a life science marketer, chances are you’ve been hearing about the difference artificial...

Pharma manufacturers work relentlessly to create drugs and therapies to address some of the most complex health conditions people face. There are years of research and...

Innovate4Outcomes® was born in 2020 as a design-thinking event in response to COVID-19, but it quickly became clear the COVID-19 health crisis could be a catalyst for a...

Unlocking the Full Potential with Artificial Intelligence in Pharma Marketing

At the recent Re:Imagine Pharma Marketing virtual conference, I was excited to present on how...

Key Themes and Takeways from Our Multiple Sclerosis Series

In our series on the challenges MS patients face in starting and staying on therapy, we’ve explored three key areas...

Part Three of Our Multiple Sclerosis Series

In our first two blog posts on challenges related to multiple sclerosis (MS) treatment, we addressed the need to build awareness...

Part Two of Our Multiple Sclerosis Series

In our initial blog post on challenges related to multiple sclerosis (MS) treatments, we discussed the first barrier, which is...

Introducing a New Series on Multiple Sclerosis

When it comes to multiple sclerosis (MS), there are multiple challenges that can deter patients from receiving the care they...

With COVID-19 still impacting provider facetime for brand field teams, life sciences organizations need new ways to deliver information that supports HCP awareness. That’s...

Omnichannel marketing continues to be a hot topic among pharma brand teams, but too often I see our clients struggling to convert their tactics and strategies into a true...

An astounding 7,000 rare and orphan diseases affect more than 30 million people in the United States alone¹. Rare diseases are classified as any disease that affects less...

As the coronavirus (COVID-19) spread across the nation, greatly impacting people’s health and lives, trustworthy and relevant health information from a reliable source became...

The annual meeting of the American Society of Clinical Oncology (ASCO) was held last month and I am excited to share with you my thoughts on the highlights from this year’s...

Like any prescribing HCP, I, as a nurse practitioner, recognized that making medication decisions was one of the biggest choices I had to make for patients. My choice had a...

Interpersonal relationships and innovative dialogue fuel my position as SVP of pharma sales at OptimizeRx. Without them, I cannot lead my team well or continue to foster and...

I recently had the honor of speaking at Momentum Events Decoding Digital Health for Life Sciences, on the value and benefits of SMS text-based patient engagement programs. I...

OptimizeRx was recently a proud Global Sponsor of Pharma USA 2021, pharma’s first “virtual congress” to look beyond the pandemic to pharma’s future. For seven days, pharma...

As a scientist, I know first-hand how much time and energy go into the drug discovery and development process from day one. In fact, one of the highlights of my research...

Lip service is often given to the idea of fostering community within the healthcare industry to improve patient outcomes, but rarely is it acted upon in significant ways.

How to support patients throughout their entire care journey is an ongoing topic of conversation in the healthcare community and one we are constantly trying to improve upon...

When we were planning our inaugural Innovate4Outcomes event, I knew it would be important to discuss topics and challenges that are omnipresent in the daily lives of our...

Patient engagement is at the forefront of what I do every day as the Vice President of Patient Engagement at OptimizeRx, so when I had the opportunity to participate in ...

Bringing our clients innovative digital solutions is the core of our purpose as a sales team at OptimizeRx. When we had the opportunity to participate in the first annual ...

As a Vice President of sales at OptimizeRx, I have taken a passionate interest in understanding how to aid both our Life Sciences and clinical partners in improving...

The onset of COVID-19 in the first quarter of 2020 forced the health industry to quickly adapt to a rapid expansion of health solutions to manage patient care in the face of...

In the United States, 45 Million Americans cannot read past a 5th grade reading level, 50% of adults cannot read past an 8th grade reading level, and ¾ of Americans on...

For the last few days, you might have noticed us celebrating our newly announced exclusive partnership with NewCrop. They’re one of the most exciting e-Prescribing services...

Medication switching by pharmacies can be one of the biggest challenges faced by LOE (loss of exclusivity)brands with the entrance of new generics in the marketplace.